Pending EO 12866 Regulatory Review

RIN: 0910-ZC16	Received Date: 10/23/2024
Title: Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers; Guidance for Industry (2023-663)
Agency/Subagency: HHS / FDA	Stage: Notice
Legal Deadline: None	Section 3(f)(1) Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No